Thalidomide, once banned for causing birth defects, does better than standard chemotherapy in stopping multiple myeloma in some patients.

Singhal, S. . . . and B. Barlogie. 1999. Antitumor activity of thalidomide in refractory multiple myeloma. New England Journal of Medicine 341(Nov. 18):1565.

Adler, T. 1994. The return of thalidomide. Science News 146(Dec. 24&31):424.

Bataille, R., and J.-L. Harousseau. 1997. Multiple myeloma. New England Journal of Medicine 336(June 5):1657.

Centofanti, M. 1995. Thalidomide heals ulcers. Science News 148(Dec. 11):311.

Lipkin, R. 1995. Deriving new drugs from thalidomide. Science News 148(Sept. 9):171.

Raje, N., and K. Anderson. 1999. Thalidomide—a revival story. New England Journal of Medicine 341(Nov. 18):1606.

Seppa, N. 1998. FDA clears thalidomide for leprosy use. Science News 154(Aug. 15):111.

Travis, J. 1999. Modus operandi of an infamous drug. Science News 155(Feb. 20):124.

Bart Barlogie
University of Arkansas for Medical Sciences
Myeloma and Transplantation Research Center
4301 West Markham, Slot 623
Little Rock, AR 72205

William I. Bensinger
Fred Hutchinson Cancer Research Center
1100 Fairview Avenue
Seattle, WA 98109

Seema Singhal
South Carolina Cancer Center
7 Richland Medical Park
Suite 600
Columbia, SC 29203

From Science News, Vol. 156, No. 21, November 20, 1999, p. 326. Copyright © 1999, Science Service.